Karnalyte Resources Valuation
Is KRN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of KRN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate KRN's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate KRN's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for KRN?
Other financial metrics that can be useful for relative valuation.
What is KRN's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | n/a |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | -3.5x |
PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does KRN's PB Ratio compare to its peers?
Company | Forward PB | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.2x | ||
ERTH Replenish Nutrients Holding | 0.5x | n/a | CA$6.4m |
EAC Earth Alive Clean Technologies | 0.5x | n/a | CA$2.9m |
BEE Bee Vectoring Technologies International | 3.9x | n/a | CA$2.1m |
WRX Western Resources | 0.1x | n/a | CA$24.5m |
KRN Karnalyte Resources | 1.2x | n/a | CA$6.4m |
Price-To-Book vs Peers: KRN is good value based on its Price-To-Book Ratio (1.2x) compared to the peer average (1.2x).
Price to Earnings Ratio vs Industry
How does KRN's PE Ratio compare vs other companies in the CA Chemicals Industry?
Price-To-Book vs Industry: KRN is expensive based on its Price-To-Book Ratio (1.2x) compared to the Canadian Chemicals industry average (1.2x).
Price to Book Ratio vs Fair Ratio
What is KRN's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PB Ratio | 1.2x |
Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate KRN's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.